Ilan Daskal
Net Worth
Last updated:
What is Ilan Daskal net worth?
The estimated net worth of Mr. Ilan Daskal is at least $16,401,671 as of 8 Apr 2023. He owns shares worth $5,163 as insider, has earned $4,796,508 from insider trading and has received compensation worth at least $11,600,000 in Bio-Rad Laboratories, Inc. and Bio-Rad Laboratories, Inc..
What is the salary of Ilan Daskal?
Mr. Ilan Daskal salary is $1,160,000 per year as Executive Vice President & Chief Financial Officer in Bio-Rad Laboratories, Inc.. He also receives $1,160,000 as Executive Vice President & Chief Financial Officer in Bio-Rad Laboratories, Inc..
How old is Ilan Daskal?
Mr. Ilan Daskal is 59 years old, born in 1966.
What stocks does Ilan Daskal currently own?
As insider, Mr. Ilan Daskal owns shares in 2 companies:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Bio-Rad Laboratories, Inc. (BIO) | Executive Vice President & Chief Financial Officer | 9 | $286.14 | $2,575 |
| Bio-Rad Laboratories, Inc. (BIO-B) | Executive Vice President & Chief Financial Officer | 9 | $287.55 | $2,588 |
What does Bio-Rad Laboratories, Inc. do?
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
What does Bio-Rad Laboratories, Inc. do?
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Ilan Daskal insider trading
Bio-Rad Laboratories, Inc.
Mr. Ilan Daskal has made 3 insider trades between 2020-2023, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 2,300 units of BIO stock on 4 Aug 2021. As of 8 Apr 2023 he still owns at least 9 units of BIO stock.
Bio-Rad Laboratories, Inc.
Mr. Ilan Daskal has made 3 insider trades between 2020-2022, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 2,300 units of BIO-B stock on 4 Aug 2021. As of 8 Apr 2023 he still owns at least 9 units of BIO-B stock.
Bio-Rad Laboratories key executives
Bio-Rad Laboratories, Inc. executives and other stock owners filed with the SEC:
- Dr. Andrew J. Last (65) Executive Vice President & Chief Operating Officer
- Mr. Ilan Daskal (59) Executive Vice President & Chief Financial Officer
- Mr. Norman D. Schwartz (75) Chairman, Chief Executive Officer & Pres
- Ms. Dara Grantham Wright (49) Executive Vice President & Pres of Clinical Diagnostics Group